230 related articles for article (PubMed ID: 28399096)
61. [Evidence-based pharmacotherapy of neuropathic pain syndromes].
Braune S
MMW Fortschr Med; 2004 Dec; 146(50):49-51. PubMed ID: 15658522
[TBL] [Abstract][Full Text] [Related]
62. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus.
Poh ZX; Goh KP
Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):392-8. PubMed ID: 19601918
[TBL] [Abstract][Full Text] [Related]
63. Diabetic neuropathy--choices of treatment.
Bruckner I; Bustan C; Adamescu E; Dobjanschi C
Rom J Intern Med; 2002; 40(1-4):53-60. PubMed ID: 15526540
[TBL] [Abstract][Full Text] [Related]
64. [Implication of alpha-lipoic acid preparations in the treatment of diabetic neuropathy].
Al'-Zamil' MKh; Brezheva EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):27-30. PubMed ID: 18427500
[TBL] [Abstract][Full Text] [Related]
65. Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study.
El-Nahas MR; Elkannishy G; Abdelhafez H; Elkhamisy ET; El-Sehrawy AA
Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1531-1534. PubMed ID: 32370731
[TBL] [Abstract][Full Text] [Related]
66. Diurnal efficacy of alpha-lipoic acid/nifedipine/glimepiride combination mitigates diabetic neuropathies in rats.
Oraebosi MI; Olurishe TO; Anafi SB; Bisalla M
Ann Pharm Fr; 2022 May; 80(3):291-300. PubMed ID: 34599891
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of Electrophysiological Effects of Melatonin and Alpha Lipoic Acid in Rats with Streptozotocine Induced Diabetic Neuropathy.
Seyit DA; Degirmenci E; Oguzhanoglu A
Exp Clin Endocrinol Diabetes; 2016 May; 124(5):300-6. PubMed ID: 27219687
[TBL] [Abstract][Full Text] [Related]
68. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.
Ruhnau KJ; Meissner HP; Finn JR; Reljanovic M; Lobisch M; Schütte K; Nehrdich D; Tritschler HJ; Mehnert H; Ziegler D
Diabet Med; 1999 Dec; 16(12):1040-3. PubMed ID: 10656234
[TBL] [Abstract][Full Text] [Related]
69. [Application of alpha-lipoic acid in clinical practice].
Lyzogub VH; Altunina NV; Bondarchuk OM
Lik Sprava; 2011; (7-8):20-8. PubMed ID: 22768734
[TBL] [Abstract][Full Text] [Related]
70. Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy.
Bertolotto F; Massone A
Drugs R D; 2012 Mar; 12(1):29-34. PubMed ID: 22329607
[TBL] [Abstract][Full Text] [Related]
71. Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials.
Kucukgoncu S; Zhou E; Lucas KB; Tek C
Obes Rev; 2017 May; 18(5):594-601. PubMed ID: 28295905
[TBL] [Abstract][Full Text] [Related]
72. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant?
Ou P; Tritschler HJ; Wolff SP
Biochem Pharmacol; 1995 Jun; 50(1):123-6. PubMed ID: 7605337
[TBL] [Abstract][Full Text] [Related]
73. [Long-term effect of 3-week intravenous alpha-lipoic acid administration in symptomatic diabetic polyneutropathy with clinical manifestations].
Ametov AS; Novosadova MV; Barinov AN; Samigullin R; Trischler HJ
Ter Arkh; 2010; 82(12):61-4. PubMed ID: 21516742
[TBL] [Abstract][Full Text] [Related]
74. Antioxidant properties of an endogenous thiol: Alpha-lipoic acid, useful in the prevention of cardiovascular diseases.
Ghibu S; Richard C; Vergely C; Zeller M; Cottin Y; Rochette L
J Cardiovasc Pharmacol; 2009 Nov; 54(5):391-8. PubMed ID: 19998523
[TBL] [Abstract][Full Text] [Related]
75. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy.
Sachse G; Willms B
Horm Metab Res Suppl; 1980; 9():105-7. PubMed ID: 6769773
[TBL] [Abstract][Full Text] [Related]
76. [Alpha-lipoic acid in diabetic neuropathy. Action mechanism and therapy. Clinical picture and pathogenesis of diabetic neuropathy].
Internist (Berl); 1994 Jun; 35(6 Alpha-liponsa):1-4. PubMed ID: 9532228
[No Abstract] [Full Text] [Related]
77. [Treatment of diabetic neuropathy with oral alpha-lipoic acid (author's transl)].
Klein W
MMW Munch Med Wochenschr; 1975 May; 117(22):957-8. PubMed ID: 807811
[TBL] [Abstract][Full Text] [Related]
78. Effects of prostaglandin E1 plus methylcobalamin alone and in combination with lipoic acid on nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.
Jiang DQ; Li MX; Wang Y; Wang Y
Neurosci Lett; 2015 May; 594():23-9. PubMed ID: 25800109
[TBL] [Abstract][Full Text] [Related]
79. Comment on Xu et al.: Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
He S; Pan YN; Zhang ZY
Diabetes Res Clin Pract; 2014 Sep; 105(3):e9. PubMed ID: 25052901
[No Abstract] [Full Text] [Related]
80. Comment on Xu et al.: Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
He F; Zhang Y; Sun L
Diabetes Res Clin Pract; 2014 May; 104(2):e33. PubMed ID: 24602352
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
